These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 11268317)

  • 21. The whys and hows of hematopoietic progenitor and stem cell mobilization.
    Kessinger A; Sharp JG
    Bone Marrow Transplant; 2003 Mar; 31(5):319-29. PubMed ID: 12634722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of renal injury in myeloablative autologous, myeloablative allogeneic and non-myeloablative allogeneic haematopoietic cell transplantation.
    Schrier RW; Parikh CR
    Nephrol Dial Transplant; 2005 Apr; 20(4):678-83. PubMed ID: 15741210
    [No Abstract]   [Full Text] [Related]  

  • 23. Full-intensity and reduced-intensity allogeneic stem cell transplantation in AML.
    Craddock CF
    Bone Marrow Transplant; 2008 Mar; 41(5):415-23. PubMed ID: 18209726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of X-linked childhood cerebral adrenoleukodystrophy by the use of an allogeneic stem cell transplantation with reduced intensity conditioning regimen.
    Resnick IB; Abdul Hai A; Shapira MY; Bitan M; Hershkovitz E; Schwartz A; Ben-Harush M; Or R; Slavin S; Kapelushnik J
    Clin Transplant; 2005 Dec; 19(6):840-7. PubMed ID: 16313334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New myeloablative conditioning regimen with fludarabine and busulfan for allogeneic stem cell transplantation: comparison with BuCy2.
    Chae YS; Sohn SK; Kim JG; Cho YY; Moon JH; Shin HJ; Chung JS; Cho GJ; Yang DH; Lee JJ; Kim YK; Kim HJ
    Bone Marrow Transplant; 2007 Sep; 40(6):541-7. PubMed ID: 17637692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal transplantation after myeloablative and non-myeloablative hematopoietic cell transplantation from the same donor.
    Tanaka T; Ishida H; Shirakawa H; Amano H; Nishida H; Tanabe K
    Int J Urol; 2007 Nov; 14(11):1044-5. PubMed ID: 17956534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Stem cells in hematology and oncology].
    Goldschmidt H; Egerer G; Fruehauf S; Ho AD
    Med Klin (Munich); 2003 Dec; 98 Suppl 2():11-4. PubMed ID: 14992195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factor analysis for thrombotic microangiopathy after reduced-intensity or myeloablative allogeneic hematopoietic stem cell transplantation.
    Nakamae H; Yamane T; Hasegawa T; Nakamae M; Terada Y; Hagihara K; Ohta K; Hino M
    Am J Hematol; 2006 Jul; 81(7):525-31. PubMed ID: 16755559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bortezomib treatment followed by a second non-myeloablative allogeneic stem cell transplant in two previously autografted patients with multiple myeloma relapse.
    Mattei D; Mordini N; Vigna Taglianti R; Bruno B; Rapezzi D; Gallamini A
    Haematologica; 2005 Jun; 90(6):861-2. PubMed ID: 15951306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Non-myeloablative allogeneic stem cell transplantation].
    Dalgaard J; Fløisand Y; Stenersen M; Egeland T; Brinch L
    Tidsskr Nor Laegeforen; 2007 Mar; 127(6):721-4. PubMed ID: 17363982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relatively favorable outcomes of post-transplant pulmonary function in patients with chronic myeloid leukemia receiving non-myeloablative allogeneic hematopoietic stem cell transplantation.
    Lee MY; Chiou TJ; Yang MH; Bai LY; Hsiao LT; Chao TC; Tung SL; Wang WS; Yen CC; Liu JH; Chen PM
    Eur J Haematol; 2005 Feb; 74(2):152-7. PubMed ID: 15654907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood stem cell mobilization and collection in patients with chronic lymphocytic leukaemia: a nationwide analysis.
    Jantunen E; Itälä M; Siitonen T; Kuittinen T; Heiskanen J; Koivunen E; Juvonen E; Silvennoinen R; Nousiainen T; Koistinen P; Volin L; Remes K
    Bone Marrow Transplant; 2008 Feb; 41(3):239-44. PubMed ID: 17968327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hematopoietic stem cell transplantation after nonmyeloablative conditioning].
    Carella AM
    Recenti Prog Med; 2001 May; 92(5):322-6. PubMed ID: 11413889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonmyeloablative allogeneic hematopoietic cell transplants: any role for rheumatoid arthritis?
    McSweeney P
    J Rheumatol Suppl; 2001 Oct; 64():49-54. PubMed ID: 11642505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized controlled trials of autologous hematopoietic stem cell transplantation for autoimmune diseases: the evolution from myeloablative to lymphoablative transplant regimens.
    Burt RK; Marmont A; Oyama Y; Slavin S; Arnold R; Hiepe F; Fassas A; Snowden J; Schuening F; Myint H; Patel DD; Collier D; Heslop H; Krance R; Statkute L; Verda L; Traynor A; Kozak T; Hintzen RQ; Rose JW; Voltarelli J; Loh Y; Territo M; Cohen BA; Craig RM; Varga J; Barr WG
    Arthritis Rheum; 2006 Dec; 54(12):3750-60. PubMed ID: 17133541
    [No Abstract]   [Full Text] [Related]  

  • 36. Onset of thymic recovery and plateau of thymic output are differentially regulated after stem cell transplantation in children.
    Eyrich M; Wollny G; Tzaribaschev N; Dietz K; Brügger D; Bader P; Lang P; Schilbach K; Winkler B; Niethammer D; Schlegel PG
    Biol Blood Marrow Transplant; 2005 Mar; 11(3):194-205. PubMed ID: 15744238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allogeneic hematopoietic stem cell transplantation for patients with severe aplastic anemia following nonmyeloablative conditioning using 200-cGy total body irradiation and fludarabine.
    Koh LP; Koh MB; Ng HY; Hwang WY; Goh YT; Linn YC; Ng HJ; Chuah CT; Tan KW; Loh YS; Tan DC; Tan PH; Tan PH
    Biol Blood Marrow Transplant; 2006 Aug; 12(8):887-90. PubMed ID: 16864060
    [No Abstract]   [Full Text] [Related]  

  • 38. Peripheral blood hematopoietic stem cell mobilization and collection efficacy is not an independent prognostic factor for autologous stem cell transplantation.
    Wang S; Nademanee A; Qian D; Dagis A; Park HS; Fridey J; Smith E; Snyder D; Somlo G; Stein A; Rosenthal J; Falk P; Kogut N; Palmer J; Gaal K; Kim Y; Bhatia R; Yuan S; Kay C; Weiss L; Forman S
    Transfusion; 2007 Dec; 47(12):2207-16. PubMed ID: 17714420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A non-myeloablative conditioning regimen in allogeneic stem cell transplantation from related and unrelated donors in elderly patients.
    Tsirigotis P; Bitan RO; Resnick IB; Samuel S; Ackerstein A; Eladì S; Gesundheit B; Zilberman I; Miron S; Leubovic A; Slavin S; Shapira MY
    Haematologica; 2006 Jun; 91(6):852-5. PubMed ID: 16769592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stem cell transplantation and hematopoietic growth factors.
    Richard S; Schuster MW
    Curr Hematol Rep; 2002 Nov; 1(2):103-9. PubMed ID: 12901131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.